Fisher Asset Management
PBYI icon

Fisher Asset Management’s Puma Biotechnology PBYI Stock Holding History

Fisher Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-29,747
Closed -$260K – 831
2019
Q4 		$260K Sell
29,747
-14,722
-33% -$122K ﹤0.01% 747
2019
Q3 		$479K Hold
44,469
– – ﹤0.01% 695
2019
Q2 		$565K Buy
44,469
+28,683
+182% +$661K ﹤0.01% 657
2019
Q1 		$612K Hold
15,786
– – ﹤0.01% 625
2018
Q4 		$321K Hold
15,786
– – ﹤0.01% 712
2018
Q3 		$724K Hold
15,786
– – ﹤0.01% 611
2018
Q2 		$934K Hold
15,786
– – ﹤0.01% 587
2018
Q1 		$1.07M Sell
15,786
-600
-4% -$44.9K ﹤0.01% 564
2017
Q4 		$1.62M Buy
16,386
+841
+5% +$94.1K ﹤0.01% 539
2017
Q3 		$1.86M Buy
+15,545
New +$1.45M ﹤0.01% 511

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management's PBYI Position: Q1 2020 in Review

Fisher Asset Management sold out of Puma Biotechnology (PBYI) in Q1 2020, closing a stake of 29,747 shares — an estimated $260K sold.

Fisher Asset Management first reported a position in PBYI in Q3 2017 and held it in 10 quarters. The position peaked at $1.86M in Q3 2017. 125 funds tracked by Wall St. Rank hold PBYI as of Q1 2020.

  • Fisher Asset Management reported no remaining Puma Biotechnology position as of Q1 2020 after selling out during the quarter.
  • Fisher Asset Management sold 29,747 Puma Biotechnology shares in Q1 2020, an estimated $260K.
  • Fisher Asset Management first reported a position in Puma Biotechnology in Q3 2017 and held it in 10 quarters.
  • Fisher Asset Management's Puma Biotechnology position peaked at $1.86M in Q3 2017.
  • 125 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2020.

Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.